Clinical Trials
Multiple clinical trials are currently evaluating interventions across therapeutic areas such as substance use disorders, renal transplantation, Dercum's disease, and atrial septal defects. Spanning Phase 2 protocols as well as non-applicable or unspecified phases, these studies are supported by academic centers like Virginia Polytechnic Institute and State University and Assistance Publique - Hôpitaux de Paris, alongside industrial entities including Caliway Biopharmaceuticals Co. Ltd. and Lifetech Scientific (Shenzhen) Co. Ltd. All of these trials currently maintain a recruitment status of not yet recruiting.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05103514 | Not yet recruiting | Substance Use Disorders |
Virginia Polytechnic Institute and State University |
2025-07-01 | -- |
| NCT06406179 | Not yet recruiting | Renal Transplantation |
Assistance Publique - Hôpitaux de Paris |
2024-06-01 | Not Applicable |
| NCT06303570 | Not yet recruiting | Dercum''s Disease |
Caliway Biopharmaceuticals Co. Ltd. |
2024-06-28 | Phase 2 |
| NCT05887700 | Not yet recruiting | Atrial Septal Defect |
Lifetech Scientific (Shenzhen) Co. Ltd. |
2024-05 | -- |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
Compliance for Clinical Use
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Jump to
- Glycolaldehyde dimer Solubility in DMSO
- Glycolaldehyde dimer Stock Solution
- Glycolaldehyde dimer Storage
- Glycolaldehyde dimer Stability
- Glycolaldehyde dimer Molecular Weight
- Glycolaldehyde dimer SMILES
- Glycolaldehyde dimer CAS Number
- Glycolaldehyde dimer Chemical Structure (2D and 3D)
- Glycolaldehyde dimer SDS|MSDS